These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
419 related items for PubMed ID: 11083267
1. Skin thickness score as a predictor and correlate of outcome in systemic sclerosis: high-dose versus low-dose penicillamine trial. Clements PJ, Hurwitz EL, Wong WK, Seibold JR, Mayes M, White B, Wigley F, Weisman M, Barr W, Moreland L, Medsger TA, Steen VD, Martin RW, Collier D, Weinstein A, Lally E, Varga J, Weiner SR, Andrews B, Abeles M, Furst DE. Arthritis Rheum; 2000 Nov; 43(11):2445-54. PubMed ID: 11083267 [Abstract] [Full Text] [Related]
2. The Disability Index of the Health Assessment Questionnaire is a predictor and correlate of outcome in the high-dose versus low-dose penicillamine in systemic sclerosis trial. Clements PJ, Wong WK, Hurwitz EL, Furst DE, Mayes M, White B, Wigley F, Weisman M, Barr W, Moreland L, Medsger TA, Steen V, Martin RW, Collier D, Weinstein A, Lally E, Varga J, Weiner SR, Andrews B, Abeles M, Seibold JR. Arthritis Rheum; 2001 Mar; 44(3):653-61. PubMed ID: 11263780 [Abstract] [Full Text] [Related]
3. Correlates of the disability index of the health assessment questionnaire: a measure of functional impairment in systemic sclerosis. Clements PJ, Wong WK, Hurwitz EL, Furst DE, Mayes M, White B, Wigley F, Weisman M, Barr W, Moreland L, Medsger TA, Steen V, Martin R, Collier D, Weinstein A, Lally E, Varga J, Weiner S, Andrews B, Abeles M, Seibold J. Arthritis Rheum; 1999 Nov; 42(11):2372-80. PubMed ID: 10555033 [Abstract] [Full Text] [Related]
4. Predictors and outcomes of scleroderma renal crisis: the high-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trial. DeMarco PJ, Weisman MH, Seibold JR, Furst DE, Wong WK, Hurwitz EL, Mayes M, White B, Wigley F, Barr W, Moreland L, Medsger TA, Steen V, Martin RW, Collier D, Weinstein A, Lally E, Varga J, Weiner SR, Andrews B, Abeles M, Clements PJ. Arthritis Rheum; 2002 Nov; 46(11):2983-9. PubMed ID: 12428241 [Abstract] [Full Text] [Related]
11. Relationship between change in skin score and disease outcome in diffuse cutaneous systemic sclerosis: application of a latent linear trajectory model. Shand L, Lunt M, Nihtyanova S, Hoseini M, Silman A, Black CM, Denton CP. Arthritis Rheum; 2007 Jul; 56(7):2422-31. PubMed ID: 17599771 [Abstract] [Full Text] [Related]
12. Treatment of systemic sclerosis with extracorporeal photochemotherapy. Results of a multicenter trial. Rook AH, Freundlich B, Jegasothy BV, Perez MI, Barr WG, Jimenez SA, Rietschel RL, Wintroub B, Kahaleh MB, Varga J. Arch Dermatol; 1992 Mar; 128(3):337-46. PubMed ID: 1550365 [Abstract] [Full Text] [Related]
14. Association of C-reactive protein with high disease activity in systemic sclerosis: results from the Canadian Scleroderma Research Group. Muangchan C, Harding S, Khimdas S, Bonner A, Canadian Scleroderma Research group, Baron M, Pope J. Arthritis Care Res (Hoboken); 2012 Sep; 64(9):1405-14. PubMed ID: 22556030 [Abstract] [Full Text] [Related]